VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

C. trachomatis DNA vaccine pWRG7079::MOMP
Vaccine Information
  • Vaccine Name: C. trachomatis DNA vaccine pWRG7079::MOMP
  • Target Pathogen: Chlamydia trachomatis
  • Target Disease: Chlamydia
  • Vaccine Ontology ID: VO_0004554
  • Type: DNA vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Pig
  • Antigen: ompA of C. trachomatis serovar E strain 468 (Schautteet et al., 2011)
  • ompA gene engineering:
    • Type: DNA vaccine construction
    • Description:
    • Detailed Gene Information: Click Here.
  • DNA vaccine plasmid:
    • DNA vaccine plasmid name:
    • DNA vaccine plasmid VO ID: VO_0005059
  • Immunization Route: Intravaginal injection
Host Response

Pig Response

  • Vaccine Immune Response Type: VO_0003057
  • Efficacy: A good level of protection against C. trachomatis genital infection was observed in the immunized group. This group had no or only mild macroscopic lesions in comparison with the control group. The infection was mainly localized in the lower genital tract while in the placebo-primed group, C. trachomatis was spread throughout the lower and upper genital tract. The scores for chlamydial presence were significantly higher for the corpus uteri, the uterine tubes and the oviducts of the control group. No replication was detected outside the urogenital tract, which is in accordance with the literature. Induction of immune mechanisms that limited infection and replication also resulted in a decreased shedding by the vaccinated pigs in comparison with the control ones. Significant differences were seen at some time points from 10 days post infection until euthanasia (Schautteet et al., 2011).
References
Schautteet et al., 2011: Schautteet K, Stuyven E, Beeckman DS, Van Acker S, Carlon M, Chiers K, Cox E, Vanrompay D. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa. Vaccine. 2011; 29(7); 1399-1407. [PubMed: 21195805].